Lyomac Logo
Case StudiesCase Study

Freeze Dryer for Diagnostic Reagents & Artificial Tissue Products

April 27, 2026Location: GlobalYear: 2025Product: LYOMAC Customized Diagnostic Lyophilizer

LYOMAC freeze drying technology propels diagnostics and regenerative medicine to new heights, from routine diagnostic reagents to cutting-edge implantable biomaterials.

Lyomac Freeze Drying Technology Propels Diagnostics and Regenerative Medicine to New Heights

In the rapidly evolving landscape of precision medicine, in vitro diagnostics (IVD), and regenerative medicine, pharmaceutical freeze dryers have emerged as indispensable tools. From routine diagnostic reagents to cutting-edge implantable biomaterials, lyophilization is the cornerstone for ensuring product activity, structural integrity, and long-term stability.

Key Features from LYOMAC

  • Highly Customizable: Whether it's high-volume standardized production for diagnostic reagents or stringent requirements for artificial tissues, LYOMAC offers in-depth customization from shelf design to process flow.
  • Technologically Advanced: Precise temperature control, crystalline structure control, and aseptic assurance technologies ensure product quality and regulatory compliance.
  • Comprehensive Service: From process development and equipment selection to installation validation and after-sales support, we provide a one-stop solution.

Meeting the Highest Standards, From Reagents to Implants

  1. Flexible Customization: Shelf dimensions, quantity, and temperature control range precisely tailored to specific client product and process requirements.
  2. Precise Crystalline Structure Control: Ultra-high precision annealing process control and linear cooling technology for controlling ice crystal size and morphology.
  3. Exceptional Shelf Temperature Uniformity: ±1°C uniformity using advanced fluid circulation temperature control system.
  4. Versatile Chamber Design: Supports vials, ampoules, microfluidic chips, large-area biological membranes, and bulk bone materials with in-situ freeze drying.
  5. Rigorous Aseptic Assurance: CIP/SIP systems, isolator compatible, cGMP/FDA compliant for Class III medical devices and injectable products.
  6. PAT and Data Traceability: SCADA system compliant with FDA 21 CFR Part 11, optional PAT tools including in-line mass spectrometers and freeze-drying microscopes.
diagnosticsIVDregenerative medicinetissue engineeringlyophilizer